TickerFacts.

PDS Biotechnology Corp (PDSB): Capital Expenditures

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$1.31M2013-12-31: $136.9K2014-12-31: $884.8K2015-12-31: $1.31M2016-12-31: $686.7K2017-12-31: $188.7K2018-12-31: $02023-12-31: $02024-12-31: $29.0K2025-12-31: $0$0
2013-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$0-100.0%2026-03-30, From 2025-01-01
2024-12-31$29.0Kn/a2026-03-30, From 2024-01-01
2023-12-31$0n/a2025-03-27, From 2023-01-01
No annual figure between 2018-12-31 and 2023-12-31.
2018-12-31$0-100.0%2019-02-21, From 2018-01-01
2017-12-31$188.7K-72.5%2019-02-21, From 2017-01-01
2016-12-31$686.7K-47.4%2018-03-01, From 2016-01-01
2015-12-31$1.31M+47.5%2018-03-01, From 2015-01-01
2014-12-31$884.8K+546.3%2017-03-02, From 2014-01-01
2013-12-31$136.9Kn/a2016-03-08, From 2013-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
PDS Biotechnology Corp (PDSB)2025-12-31$0-100.0%
Yarrow Bioscience, Inc. (YARW)2025-12-31$0-100.0%
Sunshine Biopharma Inc. (SBFM)2025-12-31$174.5K-89.5%
China Pharma Holdings, Inc. (CPHI)2025-12-31$59.3K+54.4%
Sol-Gel Technologies Ltd. (SLGL)2025-12-31$47.0Kn/m
Veru Inc. (VERU)2025-09-30$1.1K-99.3%
Talphera, Inc. (TLPH)2024-12-31$0-100.0%
Valion Bio, Inc. (VBIO)2025-12-31$38.0Kn/a
Equillium, Inc. (EQ)2025-12-31$48.0K-43.5%

Compare PDSB, YARW, SBFM, CPHI side by side · Screen every company in Pharmaceutical Preparations ↗